ARID1A and gastric cancer: In 49 non-invasive GC cases used for whole-exome sequencing and targeted sequencing, 14 samples (including two samples positive for EBV) had no major genetic mutations associated with GC, e.g., TP53, ARID1A, PIK3CA, CDH1, ROHA (Figure 2).